Suppressive effects of n-acetyl-d-glucosamine on rheumatoid arthritis mouse models

Inflammation

Volumn 35, Issue 4, 2012, Pages 1462-1465

  Azuma, Kazuo ^a   Osaki, Tomohiro ^a   Wakuda, Takashi ^a   Tsuka, Takeshi ^a   Imagawa, Tomohiro ^a   Okamoto, Yoshiharu ^a   Minami, Saburo Minami ^a  

^a Department of Veterinary Clinical Medicine ^*  (Japan)

Author keywords

D glucosamine hydrochloride; N acetyl D glucosamine; Rheumatoid arthritis; SKG jcl mice

Indexed keywords

GLUCOSAMINE; INTERLEUKIN 2; INTERLEUKIN 6; LAMINARAN; N ACETYLGLUCOSAMINE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL MODEL; FEMALE; HISTOPATHOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SUPPLEMENTATION;

ACETYLGLUCOSAMINE; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DISEASE MODELS, ANIMAL; FEMALE; GLUCOSAMINE; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-6; JOINTS; MICE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84866729243     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9459-0     Document Type: Article

References (14)

1. Anderson, J.W., R.J. Nicolosi, and J.F. Borzelleca. 2005. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food and Chemical Toxicology 43(2): 187-201.
2. Chen, J.K., C.R. Shen, and C.L. Liu. 2010. N-Acetylglucosamine: production and applications. Marine Drugs 8(9): 2493-2516.
3. Shikhman, A.R., D.C. Brinson, J. Valbracht, and M.K. Lotz. 2009. Differential metabolic effects of glucosamine and N-Acetylglucosamine in human articular chondrocytes. Osteoarthritis and Cartilage 17(8): 1022-1028.
4. Hua, J., K. Sakamoto, T. Kikukawa, C. Abe, H. Kurosawa, and I. Nagaoka. 2007. Evaluation of the suppressive actions of glucosamine on the interleukin-1beta-mediated activation of synoviocytes. Inflammation Research 56(10): 432-438.
5. Ngian, G.S. 2010. Rheumatoid arthritis. Australian Family Physician 39(9): 626-628.
6. Hua, J., S. Suguro, S. Hirano, K. Sakamoto, and I. Nagaoka. 2005. Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflammation Research 54(3): 127-132.
7. Sakaguchi, N., T. Takahashi, H. Hata, T. Nomura, T. Tagami, S. Yamazaki, T. Sakihama, T. Matsutani, I. Negishi, S. Nakatsuru, and S. Sakaguchi. 2003. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426(6965): 454-460.
8. Hata, H., N. Sakaguchi, H. Yoshitomi, Y. Iwakura, K. Sekikawa, Y. Azuma, C. Kanai, E. Moriizumi, T. Nomura, T. Nakamura, and S. Sakaguchi. 2004. Distinct contribution of IL-6, TNF-Alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. Journal of Clinical Investigation 114(4): 582-588.
9. Yoshitomi, H., N. Sakaguchi, K. Kobayashi, G.D. Brown, T. Tagami, T. Sakihama, et al. 2005. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. The Journal of Experimental Medicine 201(6): 949-960.
10. Lee, E.K., S.M. Kang, D.J. Paik, J.M. Kim, and J. Youn. 2005. Essential roles of Toll-like receptor-4 signaling in arthritis induced by type II collagen antibody and LPS. International Immunology 17(3): 325-333.
11. Hawkey, C., A. Kahan, K. Steinbrück, C. Alegre, E. Baumelou, B. Bégaud, et al. 1998. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. British Journal of Rheumatology 37(10): 937-945.
12. Bianchi, A., Bécuwe, P., Dauça, M., Netter, P., Magdalou, J., Terlain, B., and Bordji, K. 2002. Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-?B pathway. FEBS Letters 510(3): 166-170.
13. Sakaguchi, S., M. Ono, R. Setoguchi, H. Yagi, S. Hori, Z. Fehervari, J. Shimizu, T. Takahashi, and T. Nomura. 2006. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-Tolerance and autoimmune disease. Immunology Reviews 212: 8-27.
14. Nistala, K., and L.R. Wedderburn. 2009. Th17 and regulatory T cells: rebalancing pro-And anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford, England) 48(6): 602-606.